ACAAI 2013 ASM Immunotherapy Conference (DVD)

2013 ACAAI Annual Scientific Meeting: Immunotherapy Conference

Target Audience

• All practicing allergists/immunologists
• Fellows in allergy/immunology training programs
• Primary care physicians who care for allergy patients
• Allied health professionals in the field of allergy and immunology

Learning Objectives


•Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
• Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
• Translate emerging clinical science principles to clinical practice in patients with allergic and immunologicdiseases
• Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergicand immunologic diseases
• Explain the impact of environmental exposures and external influences on patients with allergic disorders
• Recognize emerging trends in the prevalence of allergicand immunologic disorders and discuss their impact on public health
• Evaluate the impact of new diagnostic and therapeuticstrategies on healthcare costs and outcomes
•Discuss processes, tools and technologies for the efficient allergy and immunology practice

Additional information
Disclosure: 

Disclosure:

Course summary
Available credit: 
  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 Attendance
Course opens: 
10/15/2014
Course expires: 
10/14/2016
Cost:
$0.00
Rating: 
0

All identified conflicts of interest have been resolved.

 Grant Anhalt, PhD

Consultant/Advisory Board: GlaxoSmithKline

Noga Askenazi, MD FACAAI

Stock: Johnson and Johnson

Amal Assa'ad, MD, FACAAI

Consultant/Advisory Board: Mead Johnson; Research Grant: DBV Technologies, Genentech, GlaxoSmithKline, Teva

Leonard Bacharier, MD, FACAAI

Consultant/Advisory Board: DVB Technologies, Merck, Teva; Speaker: Aerocrine, GlaxoSmithKline, Merck

Sami L. Bahna, MD, DrPH, FACAAI

Consultant/Advisory Board: Abbott; Speaker: Abbott; Honorarium: Abbott

Gregory Bensch, MD, FACAAI

Consultant, Speaker: Teva; Speaker: AstraZeneca.

William E. Berger, MD, MBA, FACAAI

Consultant/Advisory Board: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Speaker: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Research Grant: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva

Jonathan A. Bernstein, MD, FACAAI

Consultant/Advisory Board: CSL Behring, Dyax, Meda, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Meda, Shire, Teva, ViroPharma; Honorarium: CSL Behring, Dyax, Meda, Shire, Teva, Viropharma; Research Grant: CSL Behring, Dyax, Novartis, Shire, ViroPharma

Leonard Bielory, MD, FACAAI

Consultant/Advisory Board: Allergan, Bausch & Lomb, Merck, Pharmacal, Sanofi-Chattem; Speaker: Allergan, Bausch & Lomb, Merck; Honorarium: Allergan, Bausch & Lomb, Merck; Research Grant: Allergan, EPA; Stock: STARxTech

Clifton O. Bingham, III, MD

Consultant/Advisory Board: Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Roche, Janssen, Novartis, Novo Nordisk, Pfizer, UCB; Research Grant: Bristol-Myers Squibb, Janssen, UCB

Michael S. Blaiss, MD, FACAAI

Consultant/Advisory Board: Alcon, Allergan, Bausch & Lomb, Genentech, GlaxoSmithKline, JDP Therapeutics, Merck, Mylan, Pfizer, PMD Healthcare, Proctor & Gamble, Sanofi, Sunovion, Takeda, Teva; Speaker: Alcon, Allergan, AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Sunovion, Takeda

Don A. Bukstein, MD, FACAAI

Speaker: Aerocrine, AstraZeneca, Genentech, Merck, Novartis, Sunovion, Teva

A. Wesley Burks, MD, FACAAI

Consultant/Advisory Board: Dow AgroSciences, ExploraMed Development, Genalyte, Hycor, Mastcell Pharma, Merck, Nordic Biotech, Novartis, Perrigo Company, Regeneron, Unilever; Speaker: Mylan Specialty; Research Grant: Hycor; Stock: Allertein, Mylan Specialty

Peter A. Calabresi, MD

Consultant/Advisory Board:  Abbott, Vertex; Honorarium: Abbott, Vertex; Research Grant: Abbott, Bayer, Biogen Idec, Novartis, Vertex

Warner W. Carr, MD, FACAAI

Consultant/Advisory Board: Alcon, Allergan, Indegene, Meda; Speaker: Alcon, AstraZeneca, Meda, Teva; Honorarium: Alcon, Allergan, AstraZeneca, Indegene, Meda, Teva; Research Grant: Adrea, Forest, Sunovion

Thomas B. Casale, MD, FACAAI

Consultant/Advisory Board: Genentech, Novartis

Adrian M. Casillas, MD, FACAAI

Research Grant: CSL Behring

Bradley E. Chipps, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Speaker: AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Honorarium: AstraZeneca, Bausch & Lomb, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion

Mark L. Corbett, MD, FACAAI

Speaker: AstraZeneca, Merck, Sunovion, Teva

Linda Cox, MD, FACAAI

Consultant/Advisory Board: Genentech, Stallergenes; Speaker: Stallergenes

Timothy M Craig, DO, FACAAI

Consultant/Advisory Board: CSL Behring, Dyax. Merck; Speaker: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Honorarium: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Genentech/Novartis, GlaxoSmithKline, Merck, Pharming, Shire, ViroPharma

Peter S. Creticos, MD

Consultant/Advisory Board: Circassia, Greer, Merck; Research Grant: Circassia, Greer, Merck

Chitra Dinakar, MD, FACCAI

Speaker: Aerocrine, Teva; Honorarium: Aerocrine, Teva

Paul Dowling, MD, FACAAI

Speaker: Research Grant: GlaxoSmithKline, Merck

Mark S. Dykewicz, MD, FACAAI

Consultant/Advisory Board: Merck; Honorarium: Merck

Daniel Ein, MD, FACAAI

Consultant/Advisory Board: Allergan

Renata Engler, MD, FACAAI

Research Grant: National Institutes of Health, Stock: Stellar Biotech

Stanley M. Fineman, MD, MBA, FACAAI

Speaker: AstraZeneca, Genentech/Novartis, Sunovion; Research Grant: Genentech/Novartis, Shionogi, Sunovion

Michael B. Foggs, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck; Speaker: AstraZeneca, GlaxoSmithKline, Merck; Honorarium: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck

Luz S. Fonacier, MD, FACAAI

Speaker: Baxter; Honorarium: Genentech; Research Grant: Baxter, Dyax, Genentech, Merck

Pinkus Goldberg, FACAAI

Consultant/Advisory Board: Allergan; Speaker: Genentech, Meda, Merck, Mylan, Novartis; Research Grant: Circassia, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Teva 

Richard G. Gower, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, CSL Behring, Mylan Specialty, Dyax, Genentech, HollisterStier, Mylan, Novartis, Roche, Sanofi, Shire, Teva, ViroPharma; Speaker: Bausch & Lomb, CSL Behring, Mylan, Genentech, Novartis, Roche, Shire, Teva, ViroPharma; Honorarium: Bausch & Lomb, CSL Behring, Genentech, Mylan, Novartis, Roche, Shire, Teva, ViroPharma; Research Grant: Bausch & Lomb, Boehringer Ingelheim, Circassia,  CSL Behring, Eli Lilly, Genentech, GlaxoSmithKline, Green Cross, Kedrion, Mylan, Novartis, Pharming, Roche, Shire, Teva, ViroPharma; Stock: Merck

Matthew Greenhawt, MD, MBA, MSc

Consultant/Advisory Board: Nutricia; Research Grant: National Institutes of Health; Speaker: Nutricia; Honorarium: Nutricia

Vivian Hernandez-Trujillo, MD, FACAAI

Consultant/Advisory Board: Baxter, Merck, Sanofi; Speaker: Baxter, CSL Behring, Merck, Sanofi

Lewis Kanter, MD, FACAAI

Speaker: Alcon, Meda, Sunovion, Teva

Rohit K. Katial, MD, FACAAI

Consultant/Advisory Board: Teva; Honorarium: Teva

David A. Khan, MD, FACAAI

Speaker: Baxter, Genentech, Merck, ViroPharma; Honorarium: Baxter, Genentech, Merck, ViroPharma

Monica Kraft, MD

Research Grant: Boston Scientific, Eumedics, Genentech, GlaxoSmithKline, Merck, National Institutes of Health, Novartis

Charles J. Lane, MD

Speaker: GlaxoSmithKline; Honorarium: Mylan Specialty

Bobby Q. Lanier, MD, FACAAI

Consultant/Advisory Board: Merck, Novartis; Speaker: Merck, Novartis; Research Grant: Teva

James T. Li, MD, PhD, FACAAI

Stocks: Abbott, Johnson & Johnson, Novartis

Phillip L. Lieberman, MD, FACAAI

Consultant/Advisory Board: Meda, Mylan, Sanofi; Speaker: Meda, Mylan; Honorarium: Meda, Mylan

Todd A. Mahr, MD, FACAAI

Consultant/Advisory Board: Mylan, Sanofi; Speaker: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi; Honorarium: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi

Lyndon Mansfield, MD, FACAAI

Consultant/Advisory Board: Genentech; Speaker: Sunovion, Teva

Gailen D. Marshall, Jr., MD, PhD, FACP, FACAAI

Research Grant: Teva, National Institutes of Health, Health Resources and Services Administration

Kevin P. McGrath, MD, FACAAI

Speaker: Sunovion

Travis A. Miller, MD, FACAAI

Consultant/Advisory Board: Meda, Sunovion; Speaker: Alcon, AstraZeneca, Bausch & Lomb, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion; Teva

Anthony Montanaro, MD, FACAAI

Research Grant: Boehringer Ingelheim, Genentech, GlaxoSmithKline, Merck, Novartis, Teva

Harold S. Nelson, MD, FACAAI

Consultant/Advisory Board: Merck, Shionogi: Honorarium: Merck, Pearl, Shionogi; Research Grant: Circassia, Lincoln Diagnostics, Rigel

Talal M. Nsouli, MD, FACAAI

Consultant/Advisory Board: Thermo Fisher Scientific, Sunovion, Teva; Speaker: Thermo Fisher Scientific, Sunovion, Teva

John J. Oppenheimer, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, GlaxoSmithKline, Mylan, Sunovion; Research Grant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline

Nancy K. Ostrom, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Meda, Merck, Teva; Speaker: AstraZeneca, GlaxoSmithKline, Meda, Merck, Novartis, Sunovion, Teva; Research Grant: Apotex, AstraZeneca, Boehringer Ingelheim, ElectroCore, GlaxoSmithKline, MedImmune, Merck, Nestle, Novartis, Rigel, Sunovion, Teva, Actavis

Thomas A.E. Platts-Mills, MD, PhD, FACAAI

Consultant/Advisory Board: ViraCor-IBT, Speaker: ALK-Abello; Honorarium: ALK-Abello, Thermo Fisher Scientific; Research Grant: Thermo Fisher Scientific

Jay M. Portnoy, MD, FACAAI

Consultant/Advisory Board: Sanofi, Thermo Fisher Scientific; Speaker: Mylan, Thermo Fisher Scientific; Honorarium: Mylan, Sanofi, Thermo Fisher Scientific

Marc A. Riedl, MD, MS

Consultant/Advisory Board: BioCryst, CSL Behring, Dyax, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Shire, ViroPharma

Ketan Sheth, MD, MBA, FACAAI

Consultant/Advisory Board: Teva; Speaker: GlaxoSmithKline, Teva; Honorarium: GlaxoSmithKline, Teva; Stocks: Merck

Charles J. Siegel, MD, FACAAI

Consultant/Advisory Board: Meda, Teva; Speaker: Meda, Teva; Honorarium: Meda, Mylan, Teva

David P. Skoner, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Merck, Sunovion; Speaker: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva; Research Grant: GlaxoSmithKline, Greer, Merck, Novartis, Teva

Brett E. Stanaland, MD, MS, FACAAI

Consultant/Advisory Board: Sunovion, Teva; Speaker: Meda, Merck, Sunovion, Teva

Gary C. Steven, MD, PhD, FACAAI

Speaker: Merck, Novartis, Teva; Research Grant: Merck, AstraZeneca, Circassia, Genentech, Mylan, Novartis, Novum, Optinose, Concentric, Pulmagen, GlaxoSmithKline, Teva

James L. Sublett, MD, FACAAI

Consultant/Advisory Board: Aerocrine, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Speaker: GlaxoSmithKline, Merck, Sunovion, Teva; Honorarium: GlaxoSmithKline, Merck, Sunovion, Teva; Research Grant: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva, 

Stanley J. Szefler, MD, FACAAI

Consultant/Advisory Board: Boehringer Ingelheim, GlaxoSmithKline, Merck, Roche; Speaker: Merck; Honorarium: Genentech; Research Grant: Boehringer Ingelheim, GlaxoSmithKline

Stephen A. Tilles, MD FACAAI

Consultant/Advisory Board: Bausch & Lomb, Hycor, Merck, Mylan, Sunovion

Janna M. Tuck, MD, FACAAI

Stocks: Advanced Cell Technology, Cel-Sci, Synergy

Dana V. Wallace, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Mylan, Sanofi, Sunovion, Teva

Richard W. Weber, MD, FACAAI

Consultant/Advisory Board: Genentech; Speaker: Merck; Research Grant: Novartis

 

The following have no relevant financial relationships to disclose:

Joseph A. Bellanti, MD, FACAAI

Monica Bhagat, MD

Christina Ciaccio, MD, FACAAI

John O. Clarke, MD

Vesselin Dimov, MD

Nemr S. Eid, MD

Shari M. Erickson, MPH

Alessandro Fiocchi, MD, FACAAI (SC)

Karen A. Freedle, MD, FACAAI

Curtis L. Hedberg, MD, FACAAI

Kirsi Jarvinen-Seppo, MD, PhD

John M. Kelso, MD, FACAAI

Tao T. Le, MD, MHS, FACAAI

Alnoor A. Malick, MD, FACAAI

Jennifer Mammen, MD

Bryan L. Martin, DO, FACAAI

Kathleen May, MD, FACAAI

Michael Nelson, MD, PhD, FACAAI

Myngoc T. Nguyen, MD, FACAAI

Richard A. Nicklas, MD, FACAAI

Maeve O'Connor, MD, FACAAI

Mark T. O'Hollaren, MD, FACAAI

Gurusher Panjrath, MD

Kavita Patel, MD

Joram S. Seggev, MD, FACAAI

Meagan Shepherd, MD

David R. Weldon, MD, FACAAI

Education Staff/Committee/Reviewers have no relevant financial relationships to disclose, except as may be listed above.

Available Credit

  • 7.50 AMA PRA Category 1 Credit™
  • 7.50 Attendance

Accreditation Period

Course opens: 
10/15/2014
Course expires: 
10/14/2016

Price

Cost:
$0.00
Please login or create an account to take this course.